Financial Performance - Net loss attributable to common stockholders was $6 million, or $0.45 per diluted share[26] - Funds from operations (FFO) increased to $14.5 million, or $1.00 per share and unit, a 4% year-over-year increase[26] - Adjusted funds from operations (AFFO) increased to $16.2 million, or $1.12 per share and unit, a 4% year-over-year increase[26] - Same-store cash net operating income (NOI) growth was 2.7% year-over-year[26] Portfolio and Investment Activities - Gross investment in real estate totaled $1.5 billion[12, 32] - The company disposed of two facilities for gross proceeds of $3.8 million, resulting in a $0.3 million gain[23] - The company recognized an impairment charge of $6.3 million related to a facility in Aurora, IL[23, 26] - The weighted average portfolio cap rate is 8.1%[12, 32] - Portfolio leased occupancy was 95.2%[12, 26, 32] Debt and Capital Structure - Consolidated debt outstanding was $713 million, with a leverage ratio of 47.3%[27] - Net Debt / Annualized Adjusted EBITDAre was 6.9x for the quarter[27] - The company has $171 million borrowing capacity under the credit facility as of November 3, 2025[27]

Financial Performance - Net loss attributable to common stockholders for Q3 2025 was $6.0 million, or $0.45 per diluted share, compared to net income of $1.8 million, or $0.14 per diluted share in the prior year[3] - Funds from operations (FFO) for Q3 2025 increased to $14.5 million, or $1.00 per share, representing a 4% year-over-year increase[3] - Adjusted funds from operations (AFFO) for Q3 2025 increased to $16.2 million, or $1.12 per share, also a 4% year-over-year increase[3] - Total revenue for the three months ended September 30, 2025, was $37,229, an increase of 5.6% from $34,264 in the same period of 2024[49] - Net loss attributable to common stockholders for the three months ended September 30, 2025, was $(6,001), compared to a net income of $1,791 in the same period of 2024[51] - Funds from Operations (FFO) attributable to common stockholders for the three months ended September 30, 2025, was $14,530, up from $13,731 in the same period of 2024, representing a 5.8% increase[51] - Adjusted EBITDAre for the three months ended September 30, 2025, was $25,714, compared to $24,002 in the same period of 2024, reflecting a 7.1% increase[53] - Net Operating Income (NOI) for the three months ended September 30, 2025, was $29,005, an increase from $26,827 in the same period of 2024, indicating an 8.1% growth[55] - Cash NOI for the three months ended September 30, 2025, was $28,786, compared to $26,608 in the same period of 2024, marking an 8.2% increase[55] - Same-store cash NOI for the three months ended September 30, 2025, was $25,292, up from $24,639 in the same period of 2024, reflecting a 2.7% increase[55] Revenue and Expenses - Rental revenue for Q3 2025 increased by 8.4% year-over-year to $37.0 million, driven by acquisitions completed after September 30, 2024[5] - Total expenses for Q3 2025 were $36.3 million, up from $32.7 million in the prior year, reflecting increased G&A costs and interest expenses[6] - Interest expense for the three months ended September 30, 2025, was $8,175, an increase from $7,236 in the same period of 2024[53] - The company reported a depreciation and amortization expense of $15,008 for the three months ended September 30, 2025, compared to $13,642 in the same period of 2024[53] Assets and Liabilities - The total assets of Global Medical REIT Inc. as of September 30, 2025, amounted to $1,273,238,000, an increase from $1,256,486,000 as of December 31, 2024[47] - The total liabilities increased to $767,410,000 as of September 30, 2025, compared to $700,570,000 as of December 31, 2024[47] - The accumulated deficit rose to $(332,566,000) as of September 30, 2025, from $(293,736,000) as of December 31, 2024[47] Operational Metrics - Portfolio leased occupancy was 95.2% as of September 30, 2025, with an annualized base rent of $118.4 million[13] - Same-store cash net operating income (NOI) growth was 2.7% year-over-year for the third quarter[11] - The annualized base rent methodology produces an annualized amount as of a point in time but does not account for future contractual rental rate increases[41] - The company considers FFO and AFFO as important supplemental measures of operating performance, frequently used by analysts and investors[33] - The company calculates FAD by subtracting capital expenditures from AFFO, which is useful for analyzing cash flow available for distribution to stockholders[36] - The FAD payout ratio facilitates the comparison of dividend coverage between REITs[36] - The company defines Adjusted EBITDAre as EBITDAre plus various non-cash and normalizing items, which provides additional information for evaluating core operating results[38] - Same Store Cash NOI compares Cash NOI for stabilized properties, excluding properties recently acquired or disposed of[40] - The capitalization rate for an acquisition is calculated by dividing current annualized base rent by contractual purchase price[42] Corporate Actions - The company established a $50 million stock repurchase program in August 2025, with no shares repurchased as of November 3, 2025[20] - The company amended its credit facility on October 8, 2025, extending the maturity of the $400 million revolver to October 2029[15] - The company narrowed its full year 2025 AFFO per share guidance to a range of $4.50 to $4.60[25]

Core Viewpoint - Global Medical REIT (GMRE) is experiencing a potential recovery after a significant decline in stock value, with analysts beginning to show bullish sentiment and technical indicators suggesting a bottom may have formed [2][3][12] Company Overview - Global Medical REIT focuses on healthcare properties, including medical office buildings, outpatient facilities, and specialty care centers, supported by long-term leases and stable tenants [1] - The current stock price is $31.91, with a dividend yield of 9.40% and a P/E ratio of 91.19 [1] Stock Performance - The stock has lost over 60% of its value since December 2021, hitting all-time lows earlier this month [2] - A critical support level has emerged at $30, where buying interest has returned, indicating potential accumulation by larger funds [5][12] Analyst Sentiment - Analysts are turning bullish, with a 12-month price forecast averaging $42.50, indicating a potential upside of 33.17% from the current price [7] - Citizens JMP upgraded GMRE from Market Perform to Outperform, setting a new price target of $40, while Zacks Research upgraded it to Strong Buy [8][9] Market Environment - The broader REIT environment is improving, with expectations of interest rate cuts benefiting yield-sensitive stocks like GMRE [9] - The company has announced a $50 million share repurchase program, which adds support to the stock [9] Investment Considerations - The current dividend yield of 9.31% is attractive for income-focused investors, even if recovery takes time [10] - Despite the positive indicators, the company remains sensitive to interest rate movements and investor skepticism persists [11]

Core Viewpoint - Global Medical REIT (NYSE:GMRE) is undergoing a positive transformation, leading to an upgrade in its stock rating by Citizens [2]. Stock Performance - GMRE shares increased by 0.69% in pre-market trading, reaching a price of $31.01 [2]. Recent Developments - Over the past six months, GMRE has announced several changes that indicate its early-stage transformation [2].

Group 1 - The analyst has over 10 years of experience researching more than 1000 companies across various sectors including commodities and technology [1] - The focus has shifted from a personal blog to a value investing-oriented YouTube channel, emphasizing research on hundreds of companies [1] - The analyst expresses a particular interest in metals and mining stocks, while also being knowledgeable in consumer discretionary, staples, REITs, and utilities [1]

Group 1 - Global Medical REIT (NYSE: GMRE) is facing significant near-term refinancing liabilities that may pressure its funds from operations (FFO) and potentially dampen its dividend coverage [1] - The equity market serves as a powerful mechanism for wealth creation or destruction over the long term, with Pacifica Yield focusing on undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1]

Group 1 - Global Medical REIT (NYSE: GMRE) is facing significant near-term refinancing liabilities that may pressure its funds from operations (FFO) and potentially dampen its dividend coverage [1] - The equity market serves as a powerful mechanism for wealth creation or destruction over the long term, with Pacifica Yield focusing on undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1]

Core Insights - The market has seen significant price movements among key players, with Boxlight Corporation, AgriFORCE Growing Systems Ltd., Better Home & Finance Holding Company, and Qualigen Therapeutics, Inc. leading with substantial gains, highlighting the dynamic nature of the market driven by strategic initiatives and innovative solutions [1][5] Boxlight Corporation (BOXL) - Boxlight Corporation's stock price increased to $5.24, representing a 235.90% rise, driven by its innovative educational technology solutions and strategic partnerships [2][6] - The company has started shipping its Clevertouch Pro Series interactive displays across North America, enhancing its market presence in the education sector [2] - Boxlight has a market capitalization of approximately $4.14 million, positioning it for further expansion in the global education market [2] AgriFORCE Growing Systems Ltd. (AGRI) - AgriFORCE's stock price rose to $5.51, marking a 128.63% increase, fueled by its focus on developing plant-based ingredients and products [3][6] - The company aims to become the first publicly-traded entity focused on Avalanche on NASDAQ, with a capital raise strategy of $550 million [3] - AgriFORCE has a market cap of over $3.14 million, indicating potential for growth in the agriculture technology sector [3] Qualigen Therapeutics, Inc. (QLGN) - Qualigen's stock price increased to $5.68, reflecting a 100.03% gain, supported by its innovative healthcare solutions [4] - The company received a strategic investment of $41 million from Faraday Future, which is part of its focus on crypto business and growth engines [4] - Qualigen has a market capitalization of around $4.8 million, bolstered by its cutting-edge research and development in biotechnology [4]

Core Viewpoint - Global Medical REIT Inc. has completed a one-for-five reverse stock split of its common stock, effective at 5:00 p.m. Eastern Time today [1] Company Summary - The reverse stock split involved consolidating every five issued and outstanding shares of common stock into one share [1]

Group 1 - The investment approach has received over 500 five-star reviews, indicating high satisfaction among members who are experiencing benefits [1] - The company invests significant resources, over $100,000 annually and thousands of hours, into researching profitable real estate investment opportunities [1] - REIT share prices (VNQ) have been on a steady decline for the past three years due to rising interest rates, leading to some of the highest yields seen in many years [1] Group 2 - Jussi Askola leads the High Yield Landlord investing group, providing real-time updates on his REIT portfolio and transactions [2] - The group offers features such as three distinct portfolios (core, retirement, international), buy/sell alerts, and direct access to analysts for inquiries [2] - Jussi Askola is the President of Leonberg Capital, a value-oriented investment firm that consults various investment entities on REIT investing [2]